| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |